ArticleKidney international2015
Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
Lodi C W Roksnoer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it